Investigating the therapeutic effect of tetrabenazine in psychiatric patients with drug complications
Phase 3
Recruiting
- Conditions
- Tardive Dyskinesia.Drug induced dystoniaG24.0
- Registration Number
- IRCT20240308061212N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
Having a diagnosis of tardive dyskinesia disorder
Having at least one diagnosis of mood or psychotic disorders
Having the ability to give informed consent
Having a minimum age of 18 years and a maximum age of 65 years
Exclusion Criteria
History of neurological diseases such as epilepsy, Parkinson's, stroke and ischemic cardiac problems
History of tetrabenazine allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method AIMS test scores. Timepoint: The AIMS test will be conducted at the beginning and the 8th week of the study. Method of measurement: AIMS Movement Disorders Test.
- Secondary Outcome Measures
Name Time Method